19 results
8-K
EX-10.1
ATXI
Avenue Therapeutics Inc
2 Nov 23
Avenue Therapeutics Announces Pricing of $5.0 Million Public Offering
4:10pm
engagement shall expire on the earlier of December 31, 2023 and the final Closing Date. Notwithstanding anything to the contrary contained herein … , understandings and negotiations with respect to the subject matter hereof, including, without limitation, the Engagement Agreement, dated August 28
8-K
EX-1.1
328csb
12 Oct 22
Avenue Therapeutics Announces Pricing of $12 Million Underwritten Public Offering
9:00am
8-K
EX-3.1
jy1r7
11 Feb 19
Entry into a Material Definitive Agreement
8:39am
DEFA14A
xzzvrql87vola2
25 Jan 19
Additional proxy soliciting materials
1:56pm
DEFM14A
1n38wxhmzhmm0s8gj
21 Dec 18
Proxy related to merger
12:23pm
PREM14A
tpftpl2l 5m8a
11 Dec 18
Preliminary proxy related to merger
5:23pm
8-K
EX-10.1
9n1r4ann
14 Nov 18
Entry into a Material Definitive Agreement
12:53pm
10-12G
EX-10.5
shz g1ihhxpj77dx
12 Jan 17
Registration of securities
12:00am
10-12G
EX-3.2
uin2g41
12 Jan 17
Registration of securities
12:00am
10-12G
EX-10.8
y9k17f qi
12 Jan 17
Registration of securities
12:00am
10-12G/A
EX-10.8
9l4fx6 985
18 Feb 16
Registration of securities (amended)
12:00am
10-12G
EX-10.5
i8yf sowbp
30 Dec 15
Registration of securities
12:00am
10-12G
EX-3.3
xjnctrm7ohqk
30 Dec 15
Registration of securities
12:00am
- Prev
- 1
- Next